Skip to main content
SpringerLink
Log in

Protection by ebselen against cisplatin-induced nephrotoxicity: Antioxidant system

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

This study was designed to investigate the cisplatin-induced alteration in renal antioxidant system and the nephroprotection with ebselen. Male Wistar rats were injected with (1) vehicle control; (2) cisplatin; (3) ebselen; and (4) cisplatin plus ebselen. Rats were sacrificed three days post-treatment and plasma as well as kidney were isolated and analyzed. Plasma creatinine increased 598% following cisplatin administration alone which decreased by 158% with ebselen pretreatment. Cisplatin-treated rats showed a depletion of renal glutathione (GSH) levels (52% of control), while cisplatin plus ebselen injected rats had GSH values close to the controls. Antioxidant enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) activities decreased 38, 75 and 62% of control, respectively, and malondialdehyde (MDA) levels increased 174% of control following cisplatin administration, which were restored to control levels after ebselen treatment. The renal platinum level did not significantly change with ebselen pretreatment. This study suggests that the protection offered by ebselen against cisplatin-induced nephrotoxicity is partly related to the sparing of antioxidant system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cozzaglio L, Doci R, Colla G, Zunino F, Casciarri G, Gennari L: A feasibility study of highdose cisplatin and 5-fluorouracil with glutathione protection in the treatment of advanced colorectal cancer. Tumori 76: 590–594, 1990

    Google Scholar 

  2. Di Re F, Bohm S, Oriana S, Spatti GB, Zunino F: Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelialovarian cancer. Can Chemother Pharmacol 25: 355–360, 1990

    Google Scholar 

  3. Gandara DR, Perez EA, Weibe V, DeGregorio MW: Cisplatin chemoprotection and rescue: Pharmacologic modulation of toxicity. Semin Oncol 18: 49–55, 1991

    Google Scholar 

  4. Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF: Selective protection against cisplatin induced toxicity in kidney, gut, and bone marrow by DDTC. Cancer Res 46: 2751–2755, 1986

    Google Scholar 

  5. Hamers FPT, Brakkee JH, Cavalletti E, Tedeschi M, Marmonti L, Pezzoni G, Neijt JP, Gispen WH: Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 53: 544–549, 1993

    Google Scholar 

  6. Rybak LP, Ravi R, Somani SM: Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: Antioxidant system. Fund Appl Toxicol 26: 293–300, 1995

    Google Scholar 

  7. Wolfgang GHI, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG: Comparative nephrotoxicity of a novel platinum compound, cisplatin and carboplatin in male Wistar rats. Fundam Appl Toxicol 22: 73–79, 1994

    Google Scholar 

  8. Tognella S: Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treat Rev 17: 139–142, 1990

    Google Scholar 

  9. Hidaka S, Tsurupka M, Funakoshi T, Shimada H, Kivozumi M, Kolima S: Protective effects of dithiocarbamates against renal toxicity of cisdiamminedichloroplatinum in rats. Renal Failure 16: 337–349, 1994

    Google Scholar 

  10. Somani SM, Ravi R, Rybak LP: Diethyldithiocarbamate protection against cisplatin nephrotoxicity, Antioxidant System. Drug Chem Toxicol 18: 151–170, 1995

    Google Scholar 

  11. Qazi R, Chang AY, Borch RF, Montine T, Dedon P, Loughner J, Bennett JM: Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J Natl Can Inst 80: 1486–1488, 1988

    Google Scholar 

  12. Walker EM Jr, Fazekas-May MA, Heard KW, Yee S, Montague D, Jones MM: Prevention of cisplatin-induced toxicity by selected dithiocarbamates. Ann Clin Lab Sci 24: 121–133, 1994

    Google Scholar 

  13. Markman M, D'Acquito R, Iannoti N, Kois H, Hakes T, Bajorin D, Bosl G, Reichman B, Casper E, Magill G: Phase I trial of high dose intravenous cisplatin with simultaneous intravenous sodium thiosulphate. J Can Res Clin Oncol 117: 151–155, 1991

    Google Scholar 

  14. Yuhas JM., Culo F: Selective inhibition of the nephrotoxicity of cisdichlorodiammineplatinum (II) by WR-2721 without altering its antitumor properties. Can Treat Rep 64: 57–64, 1980

    Google Scholar 

  15. Babu E, Gopal Krishnan VK, Sriganth INP, Gopal Krishnan R, Sakthisekaran D: Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 144: 7–11, 1995

    Google Scholar 

  16. Fontanelli R, Spatti G, Raspagliesi F, Zunino F, DiRe F: A preoperative single course of high dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann Oncol 3: 117–121, 1992

    Google Scholar 

  17. Zunino F, Pratesi G, Micheloni A, Cavalletti E, Sala F, Tofanetti O: Protective effect of reduced glutahione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem Biol Interact 70: 89–101, 1989

    Google Scholar 

  18. Heyman SN, Spokes K, Egorin MJ, Epstein F: Glycine reduces early renal parenchymal uptake of cisplatin. Kidney Int 43: 1226–1228, 1993

    Google Scholar 

  19. Basinger MA, Jones MM, Holscher MA: L-methionine antagonism of cis-platinum-induced nephrotoxicity. Toxicol Appl Pharmacol 103: 1–15, 1990

    Google Scholar 

  20. Boogaard PJ, Lempers EL, Mulder GJ, Meerman JHN: 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumour activity. Biochem Pharmacol 41: 1997–2003, 1991

    Google Scholar 

  21. Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM: 4-methylthiobenzoic acid protection against cisplatic nephrotoxicity: Antioxidant system. Fundam Appl Toxicol 32: 278–284, 1996

    Google Scholar 

  22. Jones MM, Basinger MA, Holscher MA: Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res 11: 449–454, 1991

    Google Scholar 

  23. Esposito M, Viale M, Vannozi MO, Zicca A, Cadoni A, Merlo F, Gogioso L: Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis diamminedichloroplatinum (II). Toxicol Appl Pharamcol 140: 370–377, 1996

    Google Scholar 

  24. Esposito M, Fulco RA, Collecchi P, Zicca A, Cadoni A, Merlo F, Rosso R, Sobero A: Improved therapeutic index of cisplatin by procaine hydrochloride. J Natl Cancer Int 82: 677–684, 1990

    Google Scholar 

  25. Uslu R, Bonavida B: Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diammine dichloroplatinum. Cancer 77: 725–732, 1996

    Google Scholar 

  26. Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M: Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 43: 247–252, 1987

    Google Scholar 

  27. Hannemann J, Baumann K: Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 51: 119–132, 1988

    Google Scholar 

  28. McGuiness JE, Proctor P, Demopoulos H: Ameloriation of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Phys 10: 269–277, 1978

    Google Scholar 

  29. Baldew GS, Mol JG, de-Kanter FJ, van-Barr B, de-Goeij JJ, Vermeulen NP: The mechanism of interaction between cisplatin and selenite. Biochem Pharmacol 41: 1429–1437, 1991

    Google Scholar 

  30. Bull JMC, Strebel F, Sunderland BA, Bulger RE, Edwards M, Siddik ZH, Newman RA: O-(β-hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis diamminedichloroplatinum (II)/hyperthermia treatment. Cancer Res 48: 2239–2244, 1988

    Google Scholar 

  31. Maiorino M, Roveri A, Ursini F: Antioxidant effect of ebselen (Pz 51): Peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. Arch Biochem Biophys 295: 404–409, 1992

    Google Scholar 

  32. Muller A, Cadenas E, Graf P, Sies H: Glutathione peroxidase like activity in vitro and antioxidant capacity of PZ51 (ebselen). Biochem Pharmacol 33: 3235–3239, 1984

    Google Scholar 

  33. Baldew GW, McVie JW, Vander Valk MA, Los G, DeGoeij JJM, Vermeulen NPE: Selective reduction of cis-diamminedichloroplatinum (II) nephrotoxicity by ebselen. Cancer Res 50: 7031–7036, 1990

    Google Scholar 

  34. McFariss W, Reed DJ: High performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives. Meth Enzymol 143: 101–109, 1987

    Google Scholar 

  35. Misra HP, Fridovich I: The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide-dismutase. J Biol Chem 247: 3170–3175, 1972

    Google Scholar 

  36. Aebi H: Catalase in vitro. Meth Enzymol 105: 121–126, 1984

    Google Scholar 

  37. Flohe L, Gunzler W: Assays of glutathione peroxidase. Meth Enzymol 105: 114–121, 1994

    Google Scholar 

  38. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animals and tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–358, 1979

    Google Scholar 

  39. Litterst CL, Schweitzer VG: Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: Possible role in nephrotoxicity. Res Commun Chem Pathol Pharmacol 61: 35–48, 1988

    Google Scholar 

  40. Read SM, Northcole DH: Minimization of variation in the response to different protein of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116: 53–64, 1981

    Google Scholar 

  41. DeWoskin RS, Riviere JE: Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicol Appl Pharmacol 112: 182–189, 1992

    Google Scholar 

  42. Ravi R, Somani SM, Rybak LP: Mechanism of cisplatin ototoxicity: Antioxidant system. Pharmacol Toxicol 76: 386–394, 1995

    Google Scholar 

  43. Mistry P, Merazga Y, Spargo DJ, Riley PA, McBrien DCH: The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol 28: 277–282, 1991

    Google Scholar 

  44. Ban M, Hettich D, Huguet N: Nephrotoxicity mechanism of cisplatinum (II) diamine dichloride in mice. Toxicol Lett 71: 161–168, 1994

    Google Scholar 

  45. Nakano S, Gemba M: Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol 50: 87–92, 1988

    Google Scholar 

  46. Kameyama Y, Gemba M: Cisplatin-induced injury to calcium uptake by mitochondria in glutathione-depleted slices of rat kidney cortex. Jpn J Pharmacol 55: 174–176, 1991

    Google Scholar 

  47. Zhang JG, Lindup WE: Role of mitochondria in cisplatin induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol 45: 2215–2222, 1993

    Google Scholar 

  48. Younes M, Siegers CP: Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem Biol Interact 34: 257–266, 1981

    Google Scholar 

  49. Sharrna RP: Interactions of cisplatin with cellular zinc and copper in liver and kidney tissues. Pharmacol Res Commun 17: 197–206, 1985

    Google Scholar 

  50. Sinet PM, Carber P: Inactivation of the human CuZn-superoxide dismutase during exposure to O−·2 and H2O2. Arch Biochem Biophys 212: 411–416, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, 62794, USA

    K. Husain & S.M. Somani

  2. Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, 62794, USA

    C. Morris, C. Whitworth & L.P. Rybak

  3. Department of Chemistry, University of Illinois at Springfield, Shepherd Road, Springfield, IL, 62794, USA

    G.L. Trammell

Authors
  1. K. Husain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Whitworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G.L. Trammell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L.P. Rybak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S.M. Somani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Husain, K., Morris, C., Whitworth, C. et al. Protection by ebselen against cisplatin-induced nephrotoxicity: Antioxidant system. Mol Cell Biochem 178, 127–133 (1998). https://doi.org/10.1023/A:1006889427520

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006889427520

Search

Navigation